Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:BSGM

BioSig Technologies - BSGM Stock Forecast, Price & News

$0.41
+0.03 (+7.89%)
(As of 11/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.38
$0.43
50-Day Range
$0.29
$0.88
52-Week Range
$0.25
$3.11
Volume
52,290 shs
Average Volume
332,350 shs
Market Capitalization
$19.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

BioSig Technologies MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
387.8% Upside
$2.00 Price Target
Short Interest
Healthy
4.65% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.70mentions of BioSig Technologies in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$38,670 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.62) to ($0.36) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

431st out of 1,044 stocks

Electromedical Equipment Industry

7th out of 22 stocks

BSGM stock logo

About BioSig Technologies (NASDAQ:BSGM) Stock

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSGM Stock News Headlines

BSGM BioSig Technologies, Inc.
3 Medical Instruments Stocks With Potential to Outperform
BioSig Technologies, Inc. (BSGM)
See More Headlines
Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSGM Company Calendar

Last Earnings
3/31/2022
Today
11/27/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/13/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BSGM
Fax
N/A
Employees
49
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+387.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-31,920,000.00
Net Margins
-18,074.21%
Pretax Margin
-18,405.66%

Debt

Sales & Book Value

Annual Sales
$440,000.00
Book Value
$0.04 per share

Miscellaneous

Free Float
40,864,000
Market Cap
$19.30 million
Optionable
Not Optionable
Beta
1.33

Key Executives

  • Mr. Kenneth L. Londoner M.B.A.Mr. Kenneth L. Londoner M.B.A. (Age 54)
    MBA, Founder, CEO & Exec. Chairman
    Comp: $1.04M
  • Mr. Steven  Chaussy CPAMr. Steven Chaussy CPA (Age 68)
    Chief Financial Officer
  • Mr. John Sieckhaus (Age 54)
    Chief Operating Officer
  • Dr. Budimir S. Drakulic Ph.D. (Age 72)
    Chief Scientist
  • Mr. Andrew Gornell Ballou
    VP of Investor Relations
  • Ms. Brenda Castrodad
    VP of HR
  • Mr. Gray Fleming
    Chief Commercial Officer













BSGM Stock - Frequently Asked Questions

Should I buy or sell BioSig Technologies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BSGM shares.
View BSGM analyst ratings
or view top-rated stocks.

What is BioSig Technologies' stock price forecast for 2023?

1 Wall Street research analysts have issued 1-year target prices for BioSig Technologies' shares. Their BSGM share price forecasts range from $2.00 to $2.00. On average, they expect the company's stock price to reach $2.00 in the next twelve months. This suggests a possible upside of 387.8% from the stock's current price.
View analysts price targets for BSGM
or view top-rated stocks among Wall Street analysts.

How have BSGM shares performed in 2022?

BioSig Technologies' stock was trading at $2.23 at the start of the year. Since then, BSGM stock has decreased by 81.6% and is now trading at $0.41.
View the best growth stocks for 2022 here
.

When is BioSig Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023.
View our BSGM earnings forecast
.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) issued its quarterly earnings results on Thursday, March, 31st. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.02. BioSig Technologies had a negative net margin of 18,074.21% and a negative trailing twelve-month return on equity of 380.63%.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.21%), Cambridge Investment Research Advisors Inc. (0.87%), Truist Financial Corp (0.40%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, Jerome B Zeldis, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Martha Pease, Patrick Joseph Gallagher and Steve Chaussy.
View institutional ownership trends
.

How do I buy shares of BioSig Technologies?

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioSig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $0.41.

How much money does BioSig Technologies make?

BioSig Technologies (NASDAQ:BSGM) has a market capitalization of $19.30 million and generates $440,000.00 in revenue each year.

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The official website for the company is www.biosig.com. The company can be reached via phone at (230) 409-5444 or via email at info@biosigtech.com.

This page (NASDAQ:BSGM) was last updated on 11/27/2022 by MarketBeat.com Staff